Coinfection
HIV/HBV Coinfection Raises Risk of AIDS Progression and Death
- Details
- Category: HIV/HBV Coinfection
- Published on Tuesday, 13 December 2011 00:00
- Written by Liz Highleyman
Coinfection with hepatitis B virus (HBV) nearly doubled the risk of progression to AIDS or death among people recently infected with HIV, according to a study described in the December 5, 2011, advance online edition of the Journal of Infectious Diseases.
CDC Offers New HIV and Hepatitis Coinfection Fact Sheet
- Details
- Category: HIV/HBV Coinfection
- Published on Tuesday, 29 November 2011 00:00
- Written by Liz Highleyman
The U.S. Centers for Disease Control and Prevention (CDC) have produced a new fact sheet providing information about viral hepatitis in people with HIV.
Treating HIV/HBV Coinfection in Africa
- Details
- Category: HIV/HBV Coinfection
- Published on Friday, 08 July 2011 13:16
- Written by Liz Highleyman
Antiretroviral therapy regimens containing lamivudine did not provide notable benefit or reduce mortality among HIV/HBV coinfected patients in South African, suggesting that tenofovir (Viread) may be a better option.
AASLD 2011: Long-term Tenofovir for HIV/HBV Coinfection
- Details
- Category: Approved HBV Drugs
- Published on Tuesday, 08 November 2011 00:00
- Written by Liz Highleyman
Tenofovir showed long-term antiviral activity against hepatitis B virus (HBV) lasting 5 to 8 years, with minimal evidence of kidney toxicity, and HBsAg levels declined steadily over time, according to 2 posters presented this week at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2011) in San Francisco.
Additional HBV Vaccine Dose Offers More Protection for People with HIV
- Details
- Category: HBV Vaccines
- Published on Saturday, 23 April 2011 09:18
- Written by Paul Dalton
Two alternative dosing schedules of hepatitis B virus (HBV) vaccination led to higher levels of protection than the standard 3-dose schedule. 
Hepatitis B and C Coinfection among HIV Positive People in the U.S.
- Details
- Category: HIV/HBV Coinfection
- Published on Monday, 12 September 2011 00:00
- Written by Liz Highleyman
Liver disease and coinfection with hepatitis B or C are common among people with HIV, according to a recent analysis, leading researchers to recommend that viral hepatitis screening, vaccination, and treatment should be considered a priority for HIV positive individuals.
EASL 2011: Kidney Function in HIV/HBV Coinfected People on Tenofovir
- Details
- Category: HIV/HBV Coinfection
- Published on Tuesday, 19 April 2011 09:34
- Written by Liz Highleyman
Impaired kidney function among people with HIV, HBV, and HIV/HBV coinfection taking tenofovir mainly occurred in those with pre-existing risk factors, researchers reported at EASL 2011. 
Hepatitis Delta Found in 15% of HIV/HBV Coinfected People, Increases Risk of Death
- Details
- Category: Hepatitis Delta (HDV)
- Published on Thursday, 01 September 2011 00:00
- Written by Liz Highleyman
Approximately 15% of people with HIV who test positive for hepatitis B surface antigen (HBsAg) also carry hepatitis delta virus (HDV), a defective virus that can only replicate in the presence of hepatitis B virus (HBV) but can lead to more severe liver damage, according to a recent European study.
Tenofovir Remains Effective against Hepatitis B Virus after 5 Years in HIV/HBV Coinfected Patients
- Details
- Category: HIV/HBV Coinfection
- Published on Friday, 25 February 2011 03:53
- Written by Liz Highleyman
Tenofovir (Viread, also in the Truvada and Atripla combination pills) continues to potently suppress both hepatitis B virus (HBV) and HIV in coinfected patients for at least 5 years, according to a study published in the December 2010 issue of Gastroenterology. The findings support current guidelines recommending that HIV/HBV coinfected people should receive an antiretroviral therapy (ART) regimen that includes drugs with dual action against both viruses.
Web Design and Development by